SPARC mRNA Expression in Barrett's Oesophagus
Author Information
Author(s): Brabender J, Lord R V, Metzger R, Park J, Salonga D, Danenberg K D, Danenberg P V, Hölscher A H, Schneider P M
Primary Institution: University of Cologne
Hypothesis
The study aims to analyze SPARC mRNA expression in the development and progression of Barrett's oesophagus and oesophageal adenocarcinoma.
Conclusion
SPARC mRNA expression is upregulated in Barrett's oesophagus and oesophageal adenocarcinoma, indicating its potential as a biomarker for disease progression.
Supporting Evidence
- SPARC mRNA expression was detectable in all 108 specimens.
- Median SPARC mRNA expression was lowest in normal squamous oesophagus tissues and highest in adenocarcinoma.
- 18 of 20 patients with adenocarcinoma had higher SPARC expression in cancer tissues compared to normal tissues.
Takeaway
This study found that a protein called SPARC is more active in the tissues of people with Barrett's oesophagus and cancer, which might help doctors find and treat these conditions earlier.
Methodology
Tissue samples were collected from patients and analyzed for SPARC mRNA expression using quantitative real-time PCR.
Participant Demographics
31 men and 18 women, median age 60.1 years (range 24–76 years).
Statistical Information
P-Value
P<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website